An intriguing feature of our patient is that he never relapsed with Pneumocystis jirovecii pneumonia (PJP) after coming off co-trimoxazole, which would be unusual for a patient with a primary immunodeficiency predisposing to this organism, such as CD40L deficiency. This evidence concerns the gene CD40LG and immunodeficiency disease.